J. Hmeljak, F. Sanchez-vega, and K. A. Hoadley, Integrative Molecular Characterization of Malignant Pleural Mesothelioma, Cancer Discov, vol.8, pp.1548-1565, 2018.

T. Delaunay, C. Achard, and N. Boisgerault, Frequent Homozygous Deletions of Type I Interferon Genes in Pleural Mesothelioma Confer Sensitivity to Oncolytic Measles Virus, J Thorac Oncol, 2020.
URL : https://hal.archives-ouvertes.fr/inserm-02447160

C. Achard, N. Boisgerault, and T. Delaunay, Sensitivity of pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response, Oncotarget, pp.44892-44904, 0296.
URL : https://hal.archives-ouvertes.fr/inserm-01285131

A. De-reynies, M. C. Jaurand, and A. Renier, Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition, Clin Cancer Res, vol.20, pp.1323-1334, 2014.
URL : https://hal.archives-ouvertes.fr/inserm-02478599

M. Ladanyi, S. Vega, F. Zauderer, and M. , Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma, Genome Med, vol.11, p.18, 2019.

I. Canadas, R. Thummalapalli, and J. W. Kim, Tumor innate immunity primed by specific interferon-stimulated endogenous retroviruses, Nat Med, vol.24, pp.1143-1150, 2018.

Y. Blum, C. Meiller, and L. Quetel, Dissecting heterogeneity in malignant pleural mesothelioma through histo-molecular gradients for clinical applications, Nat Commun, vol.10, p.1333, 2019.
URL : https://hal.archives-ouvertes.fr/hal-02090279

L. Quetel, C. Meiller, and J. B. Assie, Genetic alterations of malignant pleural mesothelioma: association with tumor heterogeneity and overall survival, Mol Oncol, 2020.